CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net (loss) income	$ (3,075)	$ 31
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	437	587
Gain on sale of fixed assets		(5,672)
Stock-based compensation	1,097	1,356
Interest on note receivable	(93)	(70)
Bad debt provision		221
Non-cash lease expense	218
Change in fair value of contingent acquisition payment	(812)
Changes in assets and liabilities:
Accounts receivable	(3,432)	(122)
Unbilled receivables	1,387	(669)
Prepaid expenses and other current assets	(459)	(776)
Tax receivable	1,355
Accounts payable	(408)	706
Accrued expenses	363	(220)
Deferred revenue	2,180	67
Net cash used in operating activities	(1,242)	(4,561)
Cash flows from investing activities:
Purchases of property and equipment	(16)	(144)
Proceeds from sale of fixed assets		8,547
Purchase of marketable securities	(9,128)	(18,556)
Sale of marketable securities	4,750
Investment in note receivable		(2,500)
Net cash used in investing activities	(4,394)	(12,653)
Cash flows from financing activities:
Proceeds from issuance of common stock	52	96
Payments made for taxes of employees who surrendered shares related to unrestricted stock	(15)	(24)
Repurchase of common stock	(467)	(164)
Net cash used in financing activities	(430)	(92)
Decrease in cash and cash equivalents	(6,066)	(17,306)
Cash and cash equivalents, beginning of period	11,749	29,963
Cash and cash equivalents, end of period	5,683	$ 12,657
Supplemental disclosure: Cash paid for income taxes	$ 136